Reduced Toxicity and Superior Therapeutic Activity of a Mitomycin C Lipid-Based Prodrug Incorporated in Pegylated Liposomes - Concepedia

Concepedia

Publication | Closed Access

Reduced Toxicity and Superior Therapeutic Activity of a Mitomycin C Lipid-Based Prodrug Incorporated in Pegylated Liposomes

95

Citations

32

References

2006

Year

Alberto Gabizon, Dinah Tzemach, Aviva T. Horowitz, Hilary Shmeeda, Jerry Yeh, Samuel Zalipsky

Clinical Cancer Research

Abstract

Delivery of MLP in pegylated liposomes is a potential approach for effective treatment of multidrug-resistant tumors while significantly buffering the toxicity of MMC.

References

	Year	Citations

Page 1